Free Trial
NASDAQ:NRBO

NeuroBo Pharmaceuticals (NRBO) Stock Price, News & Analysis

NeuroBo Pharmaceuticals logo
$0.65 +0.01 (+2.05%)
As of 08/28/2025

About NeuroBo Pharmaceuticals Stock (NASDAQ:NRBO)

Key Stats

Today's Range
$0.63
$0.65
50-Day Range
$0.60
$0.74
52-Week Range
$2.08
$4.41
Volume
33,347 shs
Average Volume
39,605 shs
Market Capitalization
$5.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NRBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NRBO Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
NeuroBo Pharmaceuticals announces relignment, change name
See More Headlines

NRBO Stock Analysis - Frequently Asked Questions

NeuroBo Pharmaceuticals' stock was trading at $2.03 on January 1st, 2025. Since then, NRBO shares have decreased by 68.1% and is now trading at $0.6470.

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) posted its earnings results on Thursday, November, 7th. The company reported ($0.55) EPS for the quarter, beating the consensus estimate of ($0.82) by $0.27.

NeuroBo Pharmaceuticals's stock reverse split on the morning of Thursday, December 21st 2023.The 1-8 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of NRBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroBo Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
11/07/2024
Today
8/29/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Banking
Current Symbol
NASDAQ:NRBO
CIK
1638287
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-189.12%
Return on Assets
-122.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.41
Quick Ratio
2.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
8,616,000
Free Float
8,526,000
Market Cap
$5.57 million
Optionable
Not Optionable
Beta
-0.26

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:NRBO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners